Antiplatelet Therapy in Elderly Patients with Acute Coronary Syndromes: the Clopidogrel Revenge: Possible Reasons for a Bright Comeback

Cardiovasc Drugs Ther. 2021 Apr;35(2):399-401. doi: 10.1007/s10557-020-07055-0. Epub 2020 Aug 18.
No abstract available

Keywords: Acute coronary syndromes; Dual antiplatelet therapy; P2Y12 receptor inhibitors; Platelets.

Publication types

  • Letter
  • Review

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Aged
  • Aged, 80 and over
  • Clopidogrel / therapeutic use
  • Dual Anti-Platelet Therapy / adverse effects
  • Dual Anti-Platelet Therapy / methods*
  • Female
  • Glomerular Filtration Rate
  • Hemorrhage / chemically induced
  • Humans
  • Male
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Prasugrel Hydrochloride / therapeutic use
  • Purinergic P2Y Receptor Antagonists / administration & dosage
  • Purinergic P2Y Receptor Antagonists / adverse effects
  • Purinergic P2Y Receptor Antagonists / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Ticagrelor / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Clopidogrel
  • Prasugrel Hydrochloride
  • Ticagrelor